Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-04-16 5:16 pm Sale | 2024-04-02 | 13D | Rein Therapeutics Inc. RNTX | Satter Muneer A | 830,466 4.900% | -186,567 (-18.34%) | Filing History |
| 2024-03-05 4:30 pm Purchase | 2024-03-05 | 13D | Rein Therapeutics Inc. RNTX | Satter Muneer A | 1,017,033 5.900% | 9,545 (+0.95%) | Filing History |
| 2024-02-09 4:00 pm Purchase | 2023-12-31 | 13G | Akebia Therapeutics, Inc. AKBA | Satter Muneer A | 16,205,119 8.600% | 1,115,000 (+7.39%) | Filing History |
| 2023-11-03 4:30 pm Purchase | 2023-10-31 | 13D | Rein Therapeutics Inc. RNTX | Satter Muneer A | 1,007,488 19.900% | 1,007,488 (New Position) | Filing History |
| 2023-02-17 4:00 pm Purchase | 2023-02-10 | 13D | Annexon, Inc. ANNX | Satter Muneer A | 7,679,521 15.000% | 2,647,058 (+52.60%) | Filing History |
| 2023-02-10 1:08 pm Purchase | 2022-12-31 | 13G | Akebia Therapeutics, Inc. AKBA | Satter Muneer A | 15,090,119 8.200% | 1,225,789 (+8.84%) | Filing History |
| 2023-02-10 1:04 pm Purchase | 2022-12-31 | 13G | Aadi Bioscience, Inc. AADI | Satter Muneer A | 1,630,830 6.700% | 336,045 (+25.95%) | Filing History |
| 2022-12-19 4:10 pm Purchase | 2022-12-08 | 13G | Akebia Therapeutics, Inc. AKBA | Satter Muneer A | 13,864,330 7.500% | 10,797,287 (+352.04%) | Filing History |
| 2022-10-04 4:01 pm Purchase | 2022-09-26 | 13G | Aadi Bioscience, Inc. AADI | Satter Muneer A | 1,294,785 5.300% | 920,000 (+245.47%) | Filing History |
| 2022-07-18 4:45 pm Purchase | 2022-07-07 | 13D | Annexon, Inc. ANNX | Satter Muneer A | 5,032,463 10.400% | 3,077,485 (+157.42%) | Filing History |
| 2022-02-10 4:06 pm Unchanged | 2021-12-31 | 13G | Assembly Biosciences, Inc. ASMB | Satter Muneer A | 185,625 4.700% | 0 (Unchanged) | Filing History |
| 2021-11-12 4:03 pm Purchase | 2021-11-10 | 13D | Aadi Bioscience, Inc. AADI | Satter Muneer A | 374,785 1.790% | 374,785 (New Position) | Filing History |
| 2021-02-12 07:03 am Unchanged | 2020-12-31 | 13G | Assembly Biosciences, Inc. ASMB | Satter Muneer A | 185,625 6.700% | 0 (Unchanged) | Filing History |
| 2021-02-12 07:01 am Sale | 2020-12-31 | 13G | Albireo Pharma, Inc. ALBO | Satter Muneer A | 0 0.000% | -832,000 (Position Closed) | Filing History |
| 2021-02-12 07:00 am Purchase | 2020-12-31 | 13G | Annexon, Inc. ANNX | Satter Muneer A | 1,954,978 5.100% | 1,954,978 (New Position) | Filing History |
| 2021-01-08 4:04 pm Purchase | 2021-01-06 | 13D | Aileron Therapeutics, Inc. ALRN | Satter Muneer A | 1,017,040 19.900% | 450,000 (+79.36%) | Filing History |
| 2021-01-04 4:01 pm Purchase | 2020-12-22 | 13G | Assembly Biosciences, Inc. ASMB | Satter Muneer A | 185,625 6.700% | 185,625 (New Position) | Filing History |
| 2020-11-20 5:31 pm Unchanged | 2020-11-10 | 13D | Aerpio Pharmaceuticals, Inc. ARPO | Satter Muneer A | 374,789 11.900% | 0 (Unchanged) | Filing History |
| 2020-06-09 5:13 pm Purchase | 2020-06-08 | 13D | Aileron Therapeutics, Inc. ALRN | Satter Muneer A | 567,040 19.900% | 185,000 (+48.42%) | Filing History |
| 2020-02-12 10:33 am Unchanged | 2019-12-31 | 13G | Albireo Pharma, Inc. ALBO | Satter Muneer A | 832,000 5.590% | 0 (Unchanged) | Filing History |